Cargando…
Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report
Case report of a patient with severe atopic dermatitis who showed a good response to dupilumab. She had already used two immunosuppressive agents, cyclosporine A and mycophenolate mofetil, for the treatment of atopic dermatitis with no proper control of the disease. She had also been taking all meas...
Autores principales: | Giavina-Bianchi, Mara Huffenbaecher, Giavina-Bianchi, Pedro, Rizzo, Luiz Vicente |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611084/ https://www.ncbi.nlm.nih.gov/pubmed/31291386 http://dx.doi.org/10.31744/einstein_journal/2019RC4599 |
Ejemplares similares
-
Efficacy and safety of dupilumab in two adolescents with severe atopic dermatitis
por: Giavina-Bianchi, Mara, et al.
Publicado: (2021) -
Accuracy and efficiency of telemedicine in atopic dermatitis
por: Giavina-Bianchi, Mara, et al.
Publicado: (2020) -
Melanoma: tumor microenvironment and new treatments
por: Giavina-Bianchi, Mara Huffenbaecher, et al.
Publicado: (2017) -
Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023) -
Dupilumab for atopic dermatitis
Publicado: (2019)